APO Research
Talk to an analyst

APO RESEARCH · REPORT

Trastuzumab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Trastuzumab Industry Growth and Trends Forecast to 2032

26 December 202598 pages

Choose your research edition.

Industry ResearchTrastuzumab Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Trastuzumab Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Trastuzumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Trastuzumab Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Trastuzumab Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Trastuzumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Trastuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Trastuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Trastuzumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Trastuzumab include Novartis AG, Pfizer, InvivoGen, Genentech Inc, Celltrion, Bio-Techne, Biocon Limited and Abnova Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Trastuzumab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Trastuzumab market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Trastuzumab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Trastuzumab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Trastuzumab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Trastuzumab Market by Company

Novartis AG

Pfizer

InvivoGen

Genentech Inc

Celltrion

Bio-Techne

Biocon Limited

Abnova Corporation

Trastuzumab Segment by Type

Human Source

Animal Source

Trastuzumab Segment by Application

Hospital

Medical Center

Trastuzumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trastuzumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Trastuzumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trastuzumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Trastuzumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Trastuzumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Human Source Table 2. Major Company of Animal Source Table 3. Global Trastuzumab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Trastuzumab Sales by Type (2021-2026) & (Tons) Table 5. Global Trastuzumab Sales Market Share in Volume by Type (2021-2026) Table 6. Global Trastuzumab Sales by Type (2021-2026) & (US$ Million) Table 7. Global Trastuzumab Sales Market Share in Value by Type (2021-2026) Table 8. Global Trastuzumab Price by Type (2021-2026) & (US$/Ton) Table 9. Global Trastuzumab Sales by Type (2027-2032) & (Tons) Table 10. Global Trastuzumab Sales Market Share in Volume by Type (2027-2032) Table 11. Global Trastuzumab Sales by Type (2027-2032) & (US$ Million) Table 12. Global Trastuzumab Sales Market Share in Value by Type (2027-2032) Table 13. Global Trastuzumab Price by Type (2027-2032) & (US$/Ton) Table 14. North America Trastuzumab Sales by Type (2021-2026) & (Tons) Table 15. North America Trastuzumab Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Trastuzumab Sales by Type (2021-2026) & (Tons) Table 17. Europe Trastuzumab Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Trastuzumab Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Trastuzumab Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Trastuzumab Sales by Type (2021-2026) & (Tons) Table 21. Latin America Trastuzumab Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Trastuzumab Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Trastuzumab Sales by Type (2021-2026) & (US$ Million) Table 24. Trastuzumab Industry Trends Table 25. Trastuzumab Industry Drivers Table 26. Trastuzumab Industry Opportunities and Challenges Table 27. Trastuzumab Industry Restraints Table 28. Global Trastuzumab Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Trastuzumab Revenue Market Share by Company (2021-2026) Table 30. Global Trastuzumab Sales by Company (2021-2026) & (Tons) Table 31. Global Trastuzumab Sales Share by Company (2021-2026) Table 32. Global Trastuzumab Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Trastuzumab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Trastuzumab Major Company Production Sites and Headquarters Table 35. Global Trastuzumab Company, Product Type & Application Table 36. Global Trastuzumab Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Trastuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Trastuzumab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Trastuzumab Sales by Region (2021-2026) & (Tons) Table 41. Global Trastuzumab Sales Market Share in Volume by Region (2021-2026) Table 42. Global Trastuzumab Sales by Region (2021-2026) & (US$ Million) Table 43. Global Trastuzumab Sales Market Share in Value by Region (2021-2026) Table 44. Global Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Trastuzumab Sales by Region (2027-2032) & (Tons) Table 46. Global Trastuzumab Sales Market Share in Volume by Region (2027-2032) Table 47. Global Trastuzumab Sales by Region (2027-2032) & (US$ Million) Table 48. Global Trastuzumab Sales Market Share in Value by Region (2027-2032) Table 49. Global Trastuzumab Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Trastuzumab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Trastuzumab Sales by Application (2021-2026) & (Tons) Table 52. Global Trastuzumab Sales Market Share in Volume by Application (2021-2026) Table 53. Global Trastuzumab Sales by Application (2021-2026) & (US$ Million) Table 54. Global Trastuzumab Sales Market Share in Value by Application (2021-2026) Table 55. Global Trastuzumab Price by Application (2021-2026) & (US$/Ton) Table 56. Global Trastuzumab Sales by Application (2027-2032) & (Tons) Table 57. Global Trastuzumab Sales Market Share in Volume by Application (2027-2032) Table 58. Global Trastuzumab Sales by Application (2027-2032) & (US$ Million) Table 59. Global Trastuzumab Sales Market Share in Value by Application (2027-2032) Table 60. Global Trastuzumab Price by Application (2027-2032) & (US$/Ton) Table 61. North America Trastuzumab Sales by Application (2021-2026) & (Tons) Table 62. North America Trastuzumab Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Trastuzumab Sales by Application (2021-2026) & (Tons) Table 64. Europe Trastuzumab Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Trastuzumab Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Trastuzumab Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Trastuzumab Sales by Application (2021-2026) & (Tons) Table 68. Latin America Trastuzumab Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Trastuzumab Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Trastuzumab Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis AG Company Information Table 72. Novartis AG Business Overview Table 73. Novartis AG Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Novartis AG Trastuzumab Product Portfolio Table 75. Novartis AG Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Pfizer Trastuzumab Product Portfolio Table 80. Pfizer Recent Development Table 81. InvivoGen Company Information Table 82. InvivoGen Business Overview Table 83. InvivoGen Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. InvivoGen Trastuzumab Product Portfolio Table 85. InvivoGen Recent Development Table 86. Genentech Inc Company Information Table 87. Genentech Inc Business Overview Table 88. Genentech Inc Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Genentech Inc Trastuzumab Product Portfolio Table 90. Genentech Inc Recent Development Table 91. Celltrion Company Information Table 92. Celltrion Business Overview Table 93. Celltrion Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Celltrion Trastuzumab Product Portfolio Table 95. Celltrion Recent Development Table 96. Bio-Techne Company Information Table 97. Bio-Techne Business Overview Table 98. Bio-Techne Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Bio-Techne Trastuzumab Product Portfolio Table 100. Bio-Techne Recent Development Table 101. Biocon Limited Company Information Table 102. Biocon Limited Business Overview Table 103. Biocon Limited Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Biocon Limited Trastuzumab Product Portfolio Table 105. Biocon Limited Recent Development Table 106. Abnova Corporation Company Information Table 107. Abnova Corporation Business Overview Table 108. Abnova Corporation Trastuzumab Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Abnova Corporation Trastuzumab Product Portfolio Table 110. Abnova Corporation Recent Development Table 111. North America Trastuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 112. North America Trastuzumab Sales by Country (2021-2026) & (Tons) Table 113. North America Trastuzumab Sales Market Share by Country (2021-2026) Table 114. North America Trastuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 115. North America Trastuzumab Sales Market Share Forecast by Country (2027-2032) Table 116. North America Trastuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Trastuzumab Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Trastuzumab Market Share by Country (2021-2026) Table 119. North America Trastuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Trastuzumab Market Share Forecast by Country (2027-2032) Table 121. Europe Trastuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. Europe Trastuzumab Sales by Country (2021-2026) & (Tons) Table 123. Europe Trastuzumab Sales Market Share by Country (2021-2026) Table 124. Europe Trastuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 125. Europe Trastuzumab Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Trastuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Trastuzumab Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Trastuzumab Market Share by Country (2021-2026) Table 129. Europe Trastuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Trastuzumab Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Trastuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Trastuzumab Sales by Country (2021-2026) & (Tons) Table 133. Asia-Pacific Trastuzumab Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Trastuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 135. Asia-Pacific Trastuzumab Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Trastuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Trastuzumab Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Trastuzumab Market Share by Country (2021-2026) Table 139. Asia-Pacific Trastuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Trastuzumab Market Share Forecast by Country (2027-2032) Table 141. Latin America Trastuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Latin America Trastuzumab Sales by Country (2021-2026) & (Tons) Table 143. Latin America Trastuzumab Sales Market Share by Country (2021-2026) Table 144. Latin America Trastuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 145. Latin America Trastuzumab Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Trastuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Trastuzumab Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Trastuzumab Market Share by Country (2021-2026) Table 149. Latin America Trastuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Trastuzumab Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Trastuzumab Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Trastuzumab Sales by Country (2021-2026) & (Tons) Table 153. Middle East and Africa Trastuzumab Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Trastuzumab Sales Forecast by Country (2027-2032) & (Tons) Table 155. Middle East and Africa Trastuzumab Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Trastuzumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Trastuzumab Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Trastuzumab Market Share by Country (2021-2026) Table 159. Middle East and Africa Trastuzumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Trastuzumab Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Trastuzumab Distributors List Table 164. Trastuzumab Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Trastuzumab Image Figure 2. Global Trastuzumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Trastuzumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Trastuzumab Sales (2021-2032) & (Tons) Figure 5. Human Source Image Figure 6. Global Human Source Sales YoY Growth (2021-2032) & (Tons) Figure 7. Animal Source Image Figure 8. Global Animal Source Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Trastuzumab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Trastuzumab Market Share by Type 2025 VS 2032 Figure 11. North America Trastuzumab Sales Market Share in Volume by Type in 2025 Figure 12. North America Trastuzumab Sales Market Share in Value by Type in 2025 Figure 13. Europe Trastuzumab Sales Market Share in Volume by Type in 2025 Figure 14. Europe Trastuzumab Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Trastuzumab Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Trastuzumab Sales Market Share in Value by Type in 2025 Figure 17. Latin America Trastuzumab Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Trastuzumab Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Trastuzumab Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Trastuzumab Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Trastuzumab Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Tons) Figure 25. Medical Center Image Figure 26. Global Medical Center Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Trastuzumab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Trastuzumab Market Share by Application 2025 VS 2032 Figure 29. North America Trastuzumab Sales Market Share in Volume by Application in 2025 Figure 30. North America Trastuzumab Sales Market Share in Value by Application in 2025 Figure 31. Europe Trastuzumab Sales Market Share in Volume by Application in 2025 Figure 32. Europe Trastuzumab Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Trastuzumab Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Trastuzumab Sales Market Share in Value by Application in 2025 Figure 35. Latin America Trastuzumab Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Trastuzumab Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Trastuzumab Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Trastuzumab Sales Market Share in Value by Application in 2025 Figure 39. North America Trastuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Trastuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Trastuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Trastuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Trastuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Trastuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Trastuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Trastuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Trastuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Trastuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Trastuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Trastuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Trastuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Trastuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Trastuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Trastuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Trastuzumab Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Trastuzumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Trastuzumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Trastuzumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Trastuzumab Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Trastuzumab Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Human Source
  • Animal Source
Applications
  • Hospital
  • Medical Center
Companies covered
  • Novartis AG
  • Pfizer
  • InvivoGen
  • Genentech Inc
  • Celltrion
  • Bio-Techne
  • Biocon Limited
  • Abnova Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Trastuzumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Trastuzumab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Trastuzumab Market by Type
  6. 1.3.1 Human Source
  7. 1.3.2 Animal Source
  8. 1.4 Global Trastuzumab Market Size by Type
  9. 1.4.1 Global Trastuzumab Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Trastuzumab Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Trastuzumab Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Trastuzumab Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Trastuzumab Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Trastuzumab Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Trastuzumab Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Trastuzumab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Trastuzumab Industry Trends
  2. 2.2 Trastuzumab Industry Drivers
  3. 2.3 Trastuzumab Industry Opportunities and Challenges
  4. 2.4 Trastuzumab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Trastuzumab Revenue (2021-2026)
  2. 3.2 Global Top Players by Trastuzumab Sales (2021-2026)
  3. 3.3 Global Top Players by Trastuzumab Price (2021-2026)
  4. 3.4 Global Trastuzumab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Trastuzumab Major Company Production Sites & Headquarters
  6. 3.6 Global Trastuzumab Company, Product Type & Application
  7. 3.7 Global Trastuzumab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Trastuzumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Trastuzumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Trastuzumab Tier 1, Tier 2, and Tier 3
4 Trastuzumab Regional Status and Outlook
  1. 4.1 Global Trastuzumab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Trastuzumab Historic Market Size by Region
  3. 4.2.1 Global Trastuzumab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Trastuzumab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Trastuzumab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Trastuzumab Forecasted Market Size by Region
  7. 4.3.1 Global Trastuzumab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Trastuzumab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Trastuzumab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Trastuzumab by Application
  1. 5.1 Trastuzumab Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Medical Center
  4. 5.2 Global Trastuzumab Market Size by Application
  5. 5.2.1 Global Trastuzumab Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Trastuzumab Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Trastuzumab Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Trastuzumab Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Trastuzumab Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Trastuzumab Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Trastuzumab Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Trastuzumab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Trastuzumab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Trastuzumab Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Trastuzumab Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Trastuzumab Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 InvivoGen
  14. 6.3.1 InvivoGen Company Information
  15. 6.3.2 InvivoGen Business Overview
  16. 6.3.3 InvivoGen Trastuzumab Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 InvivoGen Trastuzumab Product Portfolio
  18. 6.3.5 InvivoGen Recent Developments
  19. 6.4 Genentech Inc
  20. 6.4.1 Genentech Inc Company Information
  21. 6.4.2 Genentech Inc Business Overview
  22. 6.4.3 Genentech Inc Trastuzumab Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Genentech Inc Trastuzumab Product Portfolio
  24. 6.4.5 Genentech Inc Recent Developments
  25. 6.5 Celltrion
  26. 6.5.1 Celltrion Company Information
  27. 6.5.2 Celltrion Business Overview
  28. 6.5.3 Celltrion Trastuzumab Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Celltrion Trastuzumab Product Portfolio
  30. 6.5.5 Celltrion Recent Developments
  31. 6.6 Bio-Techne
  32. 6.6.1 Bio-Techne Company Information
  33. 6.6.2 Bio-Techne Business Overview
  34. 6.6.3 Bio-Techne Trastuzumab Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bio-Techne Trastuzumab Product Portfolio
  36. 6.6.5 Bio-Techne Recent Developments
  37. 6.7 Biocon Limited
  38. 6.7.1 Biocon Limited Company Information
  39. 6.7.2 Biocon Limited Business Overview
  40. 6.7.3 Biocon Limited Trastuzumab Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biocon Limited Trastuzumab Product Portfolio
  42. 6.7.5 Biocon Limited Recent Developments
  43. 6.8 Abnova Corporation
  44. 6.8.1 Abnova Corporation Company Information
  45. 6.8.2 Abnova Corporation Business Overview
  46. 6.8.3 Abnova Corporation Trastuzumab Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Abnova Corporation Trastuzumab Product Portfolio
  48. 6.8.5 Abnova Corporation Recent Developments
7 North America by Country
  1. 7.1 North America Trastuzumab Sales by Country
  2. 7.1.1 North America Trastuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Trastuzumab Sales by Country (2021-2026)
  4. 7.1.3 North America Trastuzumab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Trastuzumab Market Size by Country
  6. 7.2.1 North America Trastuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Trastuzumab Market Size by Country (2021-2026)
  8. 7.2.3 North America Trastuzumab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Trastuzumab Sales by Country
  2. 8.1.1 Europe Trastuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Trastuzumab Sales by Country (2021-2026)
  4. 8.1.3 Europe Trastuzumab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Trastuzumab Market Size by Country
  6. 8.2.1 Europe Trastuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Trastuzumab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Trastuzumab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Trastuzumab Sales by Country
  2. 9.1.1 Asia-Pacific Trastuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Trastuzumab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Trastuzumab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Trastuzumab Market Size by Country
  6. 9.2.1 Asia-Pacific Trastuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Trastuzumab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Trastuzumab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Trastuzumab Sales by Country
  2. 10.1.1 South America Trastuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Trastuzumab Sales by Country (2021-2026)
  4. 10.1.3 South America Trastuzumab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Trastuzumab Market Size by Country
  6. 10.2.1 South America Trastuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Trastuzumab Market Size by Country (2021-2026)
  8. 10.2.3 South America Trastuzumab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Trastuzumab Sales by Country
  2. 11.1.1 Middle East and Africa Trastuzumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Trastuzumab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Trastuzumab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Trastuzumab Market Size by Country
  6. 11.2.1 Middle East and Africa Trastuzumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Trastuzumab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Trastuzumab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Trastuzumab Value Chain Analysis
  2. 12.1.1 Trastuzumab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Trastuzumab Production Mode & Process
  7. 12.2 Trastuzumab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Trastuzumab Distributors
  10. 12.2.3 Trastuzumab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst